Cardiovascular Inflammation Reduction Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The Cardiovascular Inflammation Reduction Trial (CIRT) is a randomized clinical trial investigating whether taking low‐dose methotrexate reduces heart attacks, strokes, or death in people with type 2 diabetes or metabolic syndrome that have had a heart attack or multiple coronary blockages. This trial is funded by the National Heart, Lung, and Blood Institute (NHLBI)/National Institutes of Health (NIH).
Epistemonikos ID: 8eb0c1937c69872eebae955b86a4350042263fae
First added on: May 10, 2024